Vaccine Therapy and Resiquimod in Treating Patients With Stage II-IV Melanoma That Has Been Removed By Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01748747
Recruitment Status : Completed
First Posted : December 12, 2012
Last Update Posted : October 8, 2018
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Mayo Clinic

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 14, 2014
  Actual Study Completion Date : March 30, 2017